Focus21 Inc. is a software development and digital marketing company based in Kitchener, Ontario, Canada. The company specializes in custom software solutions and digital marketing tools, helping businesses effectively navigate the technology landscape. Focus21 aims to empower organizations by leveraging technology to create robust, scalable, and user-friendly products.

The company offers a variety of services, including custom software development for web and mobile applications, digital marketing tools, UI/UX design, and integration of AI and machine learning technologies. One of their notable products is the TAS Platform, developed in collaboration with NextMed, which utilizes AI for kidney stone treatment. Focus21 emphasizes innovation and quality, ensuring that clients are actively involved throughout the project development process. With a revenue of approximately $4 million and a team of 24 employees, Focus21 is committed to delivering tailored solutions that meet the unique needs of both larger companies and startups.